NF‐κB activator Act1 associates with IL‐1/Toll pathway adaptor molecule TRAF6

Authors:
  • HSHarukazu Suzuki
    Harukazu Suzuki

Abstract
NF‐κB activator 1 (Act1), also called CIKS, is a recently identified protein with NF‐κB and AP‐1 activation activities through its association with the IκB kinase complex. We identified and confirmed that Act1 interacts with tumor necrosis factor receptor‐associated factor 6 (TRAF6); notably, Act1 binds to TRAF6 only among TRAF family proteins. The amino‐terminal half of Act1 is required for its interaction with the TRAF domain. Act1‐mediated NF‐κB activation was inhibited by a dominant‐negative mutant of TRAF6 in a dose‐dependent manner, and IL‐1‐induced NF‐κB activation was inhibited by a high level of Act1 expression. Our results suggest that Act1 is involved in IL‐1/Toll‐mediated signaling through TRAF6.

This publication has 29 references indexed in Scilit: